This cohort study is, to our knowledge, the first study to use EHR-linked exome sequencing in a large cohort to investigate the DICER1 tumor-predisposition disorder and provides critical experience regarding the strengths and limitations for genome-first investigations of monogenic tumor-predisposition disorders in general. Here, DICER1 is linked to neoplasm.